BAY-1251152
CAS No. 1610358-53-6
BAY-1251152 ( —— )
Catalog No. M23710 CAS No. 1610358-53-6
(±)-BAY-1251152 is a racemic mixture of BAY-1251152. BAY-1251152 is highly selective inhibitor of PTEF/CDK9.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
2MG | 80 | In Stock |
|
5MG | 140 | In Stock |
|
10MG | 215 | In Stock |
|
25MG | 356 | In Stock |
|
50MG | 530 | In Stock |
|
100MG | 772 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBAY-1251152
-
NoteResearch use only, not for human use.
-
Brief Description(±)-BAY-1251152 is a racemic mixture of BAY-1251152. BAY-1251152 is highly selective inhibitor of PTEF/CDK9.
-
Description(±)-BAY-1251152 is a racemic mixture of BAY-1251152. BAY-1251152 is highly selective inhibitor of PTEF/CDK9.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK9
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1610358-53-6
-
Formula Weight404.4
-
Molecular FormulaC19H18F2N4O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (123.63 mM; Need ultrasonic);H2O:< 0.1 mg/mL (insoluble)
-
SMILESN=S(CC1=CC(NC2=NC=C(F)C(C3=CC=C(F)C=C3OC)=C2)=NC=C1)(C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Tricin
Tricin can inhibit human cytomegalovirus (HCMV) replication by inhibiting CDK9.?Tricin inhibits the proliferation and invasion of C6 glioma cells via the upregulation of focal-adhesion-finase (FAK)-targeting microRNA-7.
-
23-epi-26-Deoxyactei...
23-epi-26-Deoxyactein has anti-inflammatory activity, it inhibits nitric oxide production by reducing iNOS expression without affecting activity of the enzyme. It also has anti-cancer activity, it can inhibit growth of the MCF7 human breast cancer cells and induce cell cycle arrest at G1.
-
AT-7519 trifluoroace...
A potent CDK2 inhibitor with IC50 of 47 nM; also inhibits CDK1/4/5 with IC50 of 190/67/18 nM and shows selectivity over some kinases (Aurora A, IR kinase, MEK, PDK1, c-Abl, IC50>10 uM).